The Institute of Human Virology Nigeria (IHVN) has collaborated with Breakthrough ACTION Nigeria to train media professionals and health educators on health reporting of tuberculosis in Nigeria.
In preparation for the commencement of a clinical trial to test the effectiveness of hyperimmunoglobulin as a potential treatment for COVID-19, staff of the Institute of Human Virology Nigeria (IHVN) have participated in a training on the trial.
To ensure that orphans and vulnerable children are healthy, safe and stable, Institute of Human Virology Nigeria (IHVN) has collaborated with a community-based organization, Jomurota Community Care Initiative (JCCI) to commission projects in three schools in Gwagwalada.
To find and treat more tuberculosis (TB) cases in Nigeria, Institute of Human Virology Nigeria (IHVN) and the National Tuberculosis and Leprosy Control Programme (NTBLCP) has launched a mobile application for screening and notifying TB cases by private health care providers.
To address the challenge of access to HIV medications by People Living with HIV (PLHIV) during the COVID-19 lockdown, and inter-state travel ban, Institute of Human Virology (IHVN) and other Implementing Partners (IPs) have partnered for smooth drug refills for clients stuck in states outside their hospital location.